ContractClinical Study Agreement • July 29th, 2024
Contract Type FiledJuly 29th, 2024AMENDMENT No. 1To theCLINICAL STUDY AGREEMENT 63935937MDS3001 DODATEK č. 1keSMLOUVĚ O KLINICKÉ STUDII 63935937MDS3001 This AMENDMENT No. 1 (the “Amendment”) is made as of 27 June, 2022 (the “Effective Date”) by and among Fakultni nemocnice Brno, Jihlavska 340/20, 625 00 Brno, Czech Republic, Organization ID No.: 65269705 (“Institution”), Head ofthe Internal hematology and oncology clinic Faculty hospital Brno, (“Investigator”), PAREXEL International (IRL) Limited a corporation organized under the laws of Ireland with principal place of business at 70 Sir John Rogerson’s Quay, Dublin 2, Ireland, hereinafter referred to as (“PAREXEL” or “CRO”) and Geron Corporation, a Delaware corporation with a place of business at 919 E. Hillsdale Blvd., Suite 250, Foster City, CA 94404 U.S.A. (“Geron” or “Sponsor”). Collectively Institution, Investigator, PAREXEL and Geron may each be referred to herein as a “Party” and collectively as the “Parties”. Tento DODATEK č. 1 (dále jen „dodatek“) mez